Regenerative Therapies Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

• This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global regenerative therapies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Regenerative Therapies Market, By Tissue Type:

• Allograft
• Xenograft
• Alloplast

Global Regenerative Therapies Market, By Application:

• Soft Tissue Repair
• Cardiovascular
• Dental
• Orthopedic
• CNS disease treatment
• Others

Global Regenerative Therapies Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Educational Institutes

Global Regenerative Therapies Market, By Geography:

• North America

By Country:

• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific

By Country:

• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America

By Country:

• Brazil
• Mexico
• Argentina
• Rest of Latin America

o Middle East:

By Country:

• GCC
• Israel
• Rest of Middle East
• Africa

By Country/Region:

• Central Africa
• South Africa
• North Africa
• Company Profiles
• Shire Pharmaceuticals *
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
• Kinetic Concepts, Inc.
• Mesoblast Ltd.
• Nuo Therapeutics (Cytomedix Inc.)
• Advanced Cell Technology, Inc.
• BioStem Life Sciences
• Akron Biotechnology, LLC
• Organovo Holdings Inc.
• Orgenesis Inc.
• Pluristem Therapeutics Inc.
• Genzyme
• Athersys, Inc.
• RenovaCare, Inc.
• Cytori Therapeutics, Inc.

“*” marked represents similar segmentation in other categories in the respective section.